Drug Type Small molecule drug |
Synonyms Norastemizole, Soltara, Tecastemizole (USAN/INN) + [2] |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC19H21FN4 |
InChIKeySFOVDSLXFUGAIV-UHFFFAOYSA-N |
CAS Registry75970-99-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rhinitis, Allergic, Perennial | NDA/BLA | United States | - | - |
Rhinitis, Allergic, Perennial | NDA/BLA | - | - | |
Rhinitis, Allergic, Seasonal | NDA/BLA | United States | - | - |
Rhinitis, Allergic, Seasonal | NDA/BLA | - | - |
Not Applicable | - | Tecastemizole 30 mg | noccvbjbuo(uzpkrapacg) = The number and severity of adverse events, including sedation, and changes in vital signs, were similar for TEC and PBO npfuzyvhuk (xnsjcpuqdd ) | Positive | 01 Mar 2002 | ||
Placebo |